Published in Thromb Haemost on January 21, 2016
Hemophilia Care in the Pediatric Age. J Clin Med (2017) 0.75
Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med (2007) 6.76
Surgery versus physiotherapy for stress urinary incontinence. N Engl J Med (2013) 4.95
Factor VIII products and inhibitor development in severe hemophilia A. N Engl J Med (2013) 2.99
Elevated plasma factor VIII and D-dimer levels as predictors of poor outcomes of thrombosis in children. N Engl J Med (2004) 2.60
Variable response to propranolol treatment of kaposiform hemangioendothelioma, tufted angioma, and Kasabach-Merritt phenomenon. Pediatr Blood Cancer (2012) 2.29
Comparison of characteristics from White- and Black-Americans with venous thromboembolism: a cross-sectional study. Am J Hematol (2010) 2.26
Systematic review of the role of FVIII concentrates in inhibitor development in previously untreated patients with severe hemophilia a: a 2013 update. Semin Thromb Hemost (2013) 2.19
Evidence for the transmission of parvovirus B19 in patients with bleeding disorders treated with plasma-derived factor concentrates in the era of nucleic acid test screening. Transfusion (2012) 2.19
A long-term prospective study of the natural course of sporadic adult-onset lower motor neuron syndromes. Arch Neurol (2009) 2.17
Lemierre's and Lemierre's-like syndromes in children: survival and thromboembolic outcomes. Pediatrics (2005) 1.84
Intestinal barrier dysfunction in a randomized trial of a specific probiotic composition in acute pancreatitis. Ann Surg (2009) 1.76
Assay of the von Willebrand factor (VWF) propeptide to identify patients with type 1 von Willebrand disease with decreased VWF survival. Blood (2006) 1.65
Recombinant factor XIII: a safe and novel treatment for congenital factor XIII deficiency. Blood (2012) 1.60
Efficacy and inhibitor development in previously treated patients with haemophilia A switched to a B domain-deleted recombinant factor VIII. Br J Haematol (2004) 1.52
Percutaneous mechanical and pharmacomechanical thrombolysis for occlusive deep vein thrombosis of the proximal limb in adolescent subjects: findings from an institution-based prospective inception cohort study of pediatric venous thromboembolism. J Vasc Interv Radiol (2011) 1.51
Haemostatic efficacy and safety of bolus and continuous infusion of recombinant factor VIIa are comparable in haemophilia patients with inhibitors undergoing major surgery. Results from an open-label, randomized, multicenter trial. Thromb Haemost (2007) 1.41
Starreveld scoring method in diagnosing childhood constipation. Pediatr Radiol (2010) 1.40
Phase 3 study of recombinant factor IX Fc fusion protein in hemophilia B. N Engl J Med (2013) 1.40
A thrombolytic regimen for high-risk deep venous thrombosis may substantially reduce the risk of postthrombotic syndrome in children. Blood (2007) 1.32
Impact of inherited thrombophilia on venous thromboembolism in children: a systematic review and meta-analysis of observational studies. Circulation (2008) 1.26
The thrombogram in rare inherited coagulation disorders: its relation to clinical bleeding. Thromb Haemost (2002) 1.23
Post-thrombotic syndrome in children: a systematic review of frequency of occurrence, validity of outcome measures, and prognostic factors. Haematologica (2010) 1.20
Low-dose tissue plasminogen activator thrombolysis in children. J Pediatr Hematol Oncol (2003) 1.19
Towards a consensus-based classification of childhood arterial ischemic stroke. Stroke (2011) 1.17
How we choose factor VIII to treat hemophilia. Blood (2012) 1.17
What we truly know about occupation as a risk factor for ALS: a critical and systematic review. Amyotroph Lateral Scler (2009) 1.13
Smoking, alcohol consumption, and the risk of amyotrophic lateral sclerosis: a population-based study. Am J Epidemiol (2012) 1.10
Population pharmacokinetics of recombinant factor VIII: the relationships of pharmacokinetics to age and body weight. Blood (2011) 1.09
Intensity of factor VIII treatment and inhibitor development in children with severe hemophilia A: the RODIN study. Blood (2013) 1.08
Exposure to chemicals and metals and risk of amyotrophic lateral sclerosis: a systematic review. Amyotroph Lateral Scler (2009) 1.08
Brief communication: duration of platelet dysfunction after a 7-day course of Ibuprofen. Ann Intern Med (2005) 1.06
Type and intensity of FVIII exposure on inhibitor development in PUPs with haemophilia A. A patient-level meta-analysis. Thromb Haemost (2015) 1.06
Clinical and laboratory diagnosis of von Willebrand disease: a synopsis of the 2008 NHLBI/NIH guidelines. Am J Hematol (2009) 1.05
Full-length sucrose-formulated recombinant factor VIII for treatment of previously untreated or minimally treated young children with severe haemophilia A: results of an international clinical investigation. Thromb Haemost (2005) 1.04
Sources of variability in platelet accumulation on type 1 fibrillar collagen in microfluidic flow assays. PLoS One (2013) 1.03
A new euglobulin clot lysis assay for global fibrinolysis. Thromb Res (2003) 1.02
Thrombosis during infancy and childhood: what we know and what we do not know. Hematol Oncol Clin North Am (2004) 0.97
Anticoagulation in childhood-onset arterial ischemic stroke with non-moyamoya arteriopathy: findings from the Colorado and German (COAG) collaboration. Stroke (2009) 0.96
Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A. Blood (2013) 0.96
Biomarkers of hypercoagulability and inflammation in childhood-onset arterial ischemic stroke. J Pediatr (2009) 0.93
A new global assay of coagulation and fibrinolysis. Thromb Res (2005) 0.93
Current and future approaches to inhibitor management and aversion. Semin Thromb Hemost (2006) 0.92
How I treat age-related morbidities in elderly persons with hemophilia. Blood (2009) 0.92
Early endoscopic retrograde cholangiopancreatography in predicted severe acute biliary pancreatitis: a prospective multicenter study. Ann Surg (2009) 0.92
Lymphomatous involvement of the heart in children: two cases and a review of the literature. J Pediatr Hematol Oncol (2004) 0.92
The effect of factor VIII deficiencies and replacement and bypass therapies on thrombus formation under venous flow conditions in microfluidic and computational models. PLoS One (2013) 0.91
Athletic participation in severe hemophilia: bleeding and joint outcomes in children on prophylaxis. Pediatrics (2009) 0.91
The Italian AICE-Genetics hemophilia A database: results and correlation with clinical phenotype. Haematologica (2008) 0.91
A comprehensive review of rFVIIa use in a tertiary care pediatric center. Pediatr Blood Cancer (2008) 0.91
Sensitivity of discharge diagnosis ICD-9 codes for pediatric venous thromboembolism is greater than specificity, but still suboptimal for surveillance and clinical research. Thromb Res (2011) 0.91
Progression to end-stage liver disease in patients with inherited bleeding disorders and hepatitis C: an international, multicenter cohort study. Blood (2007) 0.91
Pain and distress from bone marrow aspirations and lumbar punctures. Ann Pharmacother (2003) 0.91
Pharmacoeconomic analysis of recombinant factor VIIa versus APCC in the treatment of minor-to-moderate bleeds in hemophilia patients with inhibitors. Curr Med Res Opin (2006) 0.90
Recombinant factor VIIa in management of spontaneous subcapsular liver hematoma associated with pregnancy. Obstet Gynecol (2004) 0.90
Optimizing management of immune tolerance induction in patients with severe haemophilia A and inhibitors: towards evidence-based approaches. Br J Haematol (2010) 0.89
The laboratory approach to inherited and acquired coagulation factor deficiencies. Clin Lab Med (2009) 0.89
Quality of life of caregivers of patients with intractable epilepsy. Epilepsia (2009) 0.89
Improved treatment feasibility in children with hemophilia using arteriovenous fistulae: the results after seven years of follow-up. Haematologica (2009) 0.89
Lupus anticoagulants and their relationship with the inhibitors against coagulation factor VIII: considerations on the differentiation between the 2 circulating anticoagulants. Clin Chem (2005) 0.89
Unfavourable cardiovascular disease risk profiles in a cohort of Dutch and British haemophilia patients. Thromb Haemost (2012) 0.89
Turning severe into moderate haemophilia by prophylaxis: are we reaching our goal? Blood Transfus (2012) 0.88
Factors influencing the long-term outcome of primary total knee replacement in haemophiliacs: a review of 116 procedures at a single institution. Br J Haematol (2009) 0.88
A prospective study of recombinant activated factor VII administered by continuous infusion to inhibitor patients undergoing elective major orthopaedic surgery: a pharmacokinetic and efficacy evaluation. Br J Haematol (2003) 0.88
Validation of a new pediatric joint scoring system from the International Hemophilia Prophylaxis Study Group: validity of the hemophilia joint health score. Arthritis Care Res (Hoboken) (2011) 0.88
Feasibility of prophylaxis and immune tolerance induction regimens in haemophilic children using fully implantable central venous catheters. Br J Haematol (2008) 0.88
Von Willebrand disease: key points from the 2008 National Heart, Lung, and Blood Institute guidelines. Obstet Gynecol (2009) 0.87
High prevalence of thrombophilic traits in children with family history of thromboembolism. J Pediatr (2010) 0.87
The natural history of childhood-acquired hepatitis C infection in patients with inherited bleeding disorders. Transfusion (2006) 0.86
Coping style and quality of life in patients with epilepsy: a cross-sectional study. J Neurol (2010) 0.86
Coping style and health-related quality of life in caregivers of epilepsy patients. J Neurol (2011) 0.85
The "parallel-cohort RCT": Novel design aspects and application in the Kids-DOTT trial of pediatric venous thromboembolism. Contemp Clin Trials (2009) 0.85
The natural history of hepatitis C virus infection in Italian patients with von Willebrand's disease: a cohort study. Haematologica (2006) 0.84
Requirements for immune recognition and processing of factor VIII by antigen-presenting cells. Blood Rev (2011) 0.84
Cost-utility analysis of prophylaxis versus treatment on demand in severe hemophilia A. Clinicoecon Outcomes Res (2011) 0.84
Acute lymphoblastic leukemia presenting with gross hematuria. Paediatr Child Health (2007) 0.84
Gene mutations and three-dimensional structural analysis in 13 families with severe factor X deficiency. Br J Haematol (2002) 0.84
Consumption of clotting factors in severe haemophilia patients undergoing prophylaxis and on-demand treatment in Italy. Transfus Med (2011) 0.84
Safety and efficacy of sucrose-formulated full-length recombinant factor VIII: experience in the standard clinical setting. Thromb Haemost (2008) 0.84
Effects of vaginal prolapse surgery on sexuality in women and men; results from a RCT on repair with and without mesh. J Sex Med (2012) 0.84
Chronic hepatitis B and other correlates of spontaneous clearance of hepatitis C virus among HIV-infected people with hemophilia. AIDS (2007) 0.84
Barrett's esophagus in children: does it need more attention? Dig Liver Dis (2011) 0.83
Sustained cyclosporine-induced erythropoietic response in identical male twins with diamond-blackfan anemia. J Pediatr Hematol Oncol (2003) 0.83
Validation of upper extremity post-thrombotic syndrome outcome measurement in children. J Pediatr (2010) 0.83
Hepatitis C virus (HCV) coinfection in a cohort of HIV positive long-term non-progressors: possible protective effect of infecting HCV genotype on HIV disease progression. J Clin Virol (2007) 0.83
The methylenetetrahydrofolate reductase polymorphism (MTHFR c.677C>T) and elevated plasma homocysteine levels in a U.S. pediatric population with incident thromboembolism. Thromb Res (2013) 0.83
Childhood acute immune thrombocytopenic purpura: 20 years later. Semin Thromb Hemost (2003) 0.82
Evidence for the continued transmission of parvovirus B19 in patients with bleeding disorders treated with plasma-derived factor concentrates. Transfusion (2013) 0.82
Beyond patient benefit: clinical development in hemophilia. Hematology (2012) 0.82
Replacement therapy with recombinant factor IX. A multicentre evaluation of current dosing practices in Italy. Blood Transfus (2010) 0.82
Inherited abnormalities of coagulation: hemophilia, von Willebrand disease, and beyond. Pediatr Clin North Am (2013) 0.82
High efficacy of combined therapy with pegylated interferon plus ribavirin in patients with hemophilia and chronic hepatitis C. Haematologica (2006) 0.82
IDO1 suppresses inhibitor development in hemophilia A treated with factor VIII. J Clin Invest (2015) 0.81
Elevated lipoprotein (a), small apolipoprotein (a), and the risk of arterial ischemic stroke in North American children. Haematologica (2013) 0.81
Development and definition of a simplified scanning procedure and scoring method for Haemophilia Early Arthropathy Detection with Ultrasound (HEAD-US). Thromb Haemost (2013) 0.81
Thrombotic events in neonates receiving recombinant factor VIIa or fresh frozen plasma. Pediatr Blood Cancer (2009) 0.81